Skip to main content

Table 1 Association of Aur-A expression with clinicopathological parameters

From: Aurora-A down-regulates IkappaBα via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival

Clinicopathological features

n

Aur-A expression

Positive No.(%)

χ2

P

Age

≤ 60 years

28

20 (71.4)

0.900

0.343

 

>60 years

27

16 (59.3)

  

Gender

Male

33

22 (66.7)

0.054

0.817

 

Female

22

14 (63.6)

  

Clinical Stage

I+II

19

8 (42.1)

6.999

0.008

 

III+IV

36

28 (77.8)

  

Differentiation

Well

7

2 (28.6)

4.952

0.084

 

Moderate

26

19 (73.1)

  
 

Poor

22

15 (68.2)

  

Lymph node metastasis

Positive

16

14 (87.5)

4.850

0.028

 

Negative

39

22 (56.4)